Portfolio Holdings Detail for ISIN IE00BFYTYS33
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Edge MSCI World Value Factor UCITS USD Dist
Issuer Blackrock

ETF Ticker IWVG(GBP) LSE
ETF Ticker IWVU(USD) LSE
ETF Ticker IWVU.LS(USD) CXE
ETF Ticker IWVUx(GBP) CXE
ETF Ticker IWVG.L(GBP) LSE
ETF Ticker IWVU.L(GBP) LSE

Holdings detail for INCY

Stock Name	Incyte Corporation
Ticker	INCY(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US45337C1027
LEI	549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price: In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib: (RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update: Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts: Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.: Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY): Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00: Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts: Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price: In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY): Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC: Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY): Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.: Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.: Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY): Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC: Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY): Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY): State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY): Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY): Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC: Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY): Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus: Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares Edge MSCI World Value Factor UCITS USD Dist INCY holdings

Date	Number of INCY Shares Held	Base Market Value of INCY Shares	Local Market Value of INCY Shares	Change in INCY Shares Held	Change in INCY Base Value	Current Price per INCY Share Held	Previous Price per INCY Share Held
2025-11-27 (Thursday)	26,650	USD 2,815,573	USD 2,815,573	0	USD 0	USD 105.65	USD 105.65
2025-11-26 (Wednesday)	26,650	USD 2,815,573	USD 2,815,573	0	USD 2,665	USD 105.65	USD 105.55
2025-11-25 (Tuesday)	26,650	USD 2,812,908	USD 2,812,908	135	USD -4,046	USD 105.55	USD 106.24
2025-11-24 (Monday)	26,515	USD 2,816,954	USD 2,816,954	-3,375	USD -233,619	USD 106.24	USD 102.06
2025-11-21 (Friday)	29,890	USD 3,050,573	USD 3,050,573	0	USD 8,967	USD 102.06	USD 101.76
2025-11-20 (Thursday)	29,890	USD 3,041,606	USD 3,041,606	0	USD 13,151	USD 101.76	USD 101.32
2025-11-19 (Wednesday)	29,890	USD 3,028,455	USD 3,028,455	0	USD -76,817	USD 101.32	USD 103.89
2025-11-18 (Tuesday)	29,890	USD 3,105,272	USD 3,105,272	28	USD -5,453	USD 103.89	USD 104.17
2025-11-17 (Monday)	29,862	USD 3,110,725	USD 3,110,725	112	USD 12,262	USD 104.17	USD 104.15
2025-11-14 (Friday)	29,750	USD 3,098,463	USD 3,098,463	84	USD -28,630	USD 104.15	USD 105.41
2025-11-13 (Thursday)	29,666	USD 3,127,093	USD 3,127,093	0	USD -84,548	USD 105.41	USD 108.26
2025-11-12 (Wednesday)	29,666	USD 3,211,641	USD 3,211,641	0	USD 2,966	USD 108.26	USD 108.16

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00BFYTYS33

Show aggregate share trades of INCY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-25 BUY 135 107.605 105.160 105.405 USD 14,230 73.83
2025-11-24 SELL -3,375 106.670 102.503 102.920 USD -347,354 73.68 Loss of -98,667 on sale
2025-11-18 BUY 28 107.265 103.790 104.137 USD 2,916 73.18
2025-11-17 BUY 112 105.970 103.830 104.044 USD 11,653 73.04
2025-11-14 BUY 84 106.920 103.770 104.085 USD 8,743 72.90
2025-11-11 SELL -330 108.670 105.530 105.844 USD -34,929 72.43 Loss of -11,027 on sale
2025-11-10 BUY 504 108.810 104.070 104.544 USD 52,690 72.28
2025-10-22 BUY 90 88.060 88.210 88.195 USD 7,938 70.77
2025-10-15 BUY 90 88.150 88.490 88.456 USD 7,961 70.35
2025-09-24 BUY 120 84.160 84.820 84.754 USD 10,170 69.68
2025-09-16 BUY 60 83.900 84.580 84.512 USD 5,071 69.44
2025-09-11 BUY 58 86.170 87.100 87.007 USD 5,046 69.35
2025-09-10 BUY 60 86.250 86.940 86.871 USD 5,212 69.26
2025-09-09 BUY 30 85.600 87.350 87.175 USD 2,615 69.17
2025-09-08 BUY 60 86.560 86.940 86.902 USD 5,214 69.08
2025-08-15 BUY 300 86.920 87.060 87.046 USD 26,114 68.50
2025-07-14 SELL -90 69.980 70.040 70.034 USD -6,303 68.20 Loss of -165 on sale
2025-06-25 SELL -180 67.550 69.140 68.981 USD -12,417 68.17 Loss of -145 on sale
2025-06-20 SELL -120 68.460 69.190 69.117 USD -8,294 68.17 Loss of -113 on sale
2025-06-02 SELL -360 65.310 65.970 65.904 USD -23,725 68.15 Profit of 807 on sale
2025-05-30 BUY 4,576 65.060 65.770 65.699 USD 300,639 68.17
2025-05-27 SELL -275 65.350 65.800 65.755 USD -18,083 68.23 Profit of 680 on sale
2025-05-19 SELL -200 63.810 64.300 64.251 USD -12,850 68.40 Profit of 830 on sale
2025-05-15 SELL -200 62.760 62.990 62.967 USD -12,593 68.48 Profit of 1,103 on sale
2025-05-14 SELL -100 61.160 62.500 62.366 USD -6,237 68.54 Profit of 618 on sale
2025-04-24 SELL -50 58.970 59.050 59.042 USD -2,952 69.54 Profit of 525 on sale
2025-04-22 SELL -75 57.380 58.040 57.974 USD -4,348 69.75 Profit of 883 on sale
2025-04-10 BUY 101 55.170 58.330 58.014 USD 5,859 70.70
2025-04-09 BUY 90 58.860 59.370 59.319 USD 5,339 70.81
2025-04-07 SELL -408 60.290 61.060 60.983 USD -24,881 71.06 Profit of 4,110 on sale
2025-04-01 SELL -206 60.910 62.000 61.891 USD -12,750 71.36 Profit of 1,951 on sale
2025-03-28 BUY 102 60.600 60.970 60.933 USD 6,215 71.59
2025-03-21 BUY 100 61.920 62.330 62.289 USD 6,229 72.13
2025-03-19 BUY 101 60.340 61.150 61.069 USD 6,168 72.40
2025-03-11 BUY 200 68.070 71.650 71.292 USD 14,258 72.90
2025-03-07 BUY 196 70.790 72.810 72.608 USD 14,231 72.95
2025-02-28 BUY 98 73.500 73.630 73.617 USD 7,214 73.06
2025-02-20 BUY 99 71.380 71.520 71.506 USD 7,079 73.05
2025-02-03 SELL -480 73.740 75.000 74.874 USD -35,940 73.42 Loss of -697 on sale
2025-01-31 SELL -97 74.160 75.180 75.078 USD -7,283 73.41 Loss of -162 on sale
2025-01-23 SELL -97 72.530 72.880 72.845 USD -7,066 73.45 Profit of 59 on sale
2024-12-09 SELL -100 72.110 75.980 75.593 USD -7,559 73.50 Loss of -210 on sale
2024-12-04 SELL -99 74.620 75.320 75.250 USD -7,450 73.39 Loss of -184 on sale
2024-11-29 SELL -198 74.590 76.080 75.931 USD -15,034 73.39 Loss of -502 on sale
2024-11-25 SELL -6,950 73.520 73.870 73.835 USD -513,153 73.25 Loss of -4,093 on sale
2024-11-22 SELL -124 71.720 72.000 71.972 USD -8,925 73.29 Profit of 163 on sale
2024-11-21 SELL -124 70.390 71.400 71.299 USD -8,841 73.37 Profit of 257 on sale
2024-11-05 SELL -123 77.280 77.370 77.361 USD -9,515 69.60 Loss of -955 on sale
2024-11-05 SELL -123 77.280 77.370 77.361 USD -9,515 69.60 Loss of -955 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-25	BUY	135	107.605	105.160	105.405	USD 14,230	73.83
2025-11-24	SELL	-3,375	106.670	102.503	102.920	USD -347,354	73.68 Loss of -98,667 on sale
2025-11-18	BUY	28	107.265	103.790	104.137	USD 2,916	73.18
2025-11-17	BUY	112	105.970	103.830	104.044	USD 11,653	73.04
2025-11-14	BUY	84	106.920	103.770	104.085	USD 8,743	72.90
2025-11-11	SELL	-330	108.670	105.530	105.844	USD -34,929	72.43 Loss of -11,027 on sale
2025-11-10	BUY	504	108.810	104.070	104.544	USD 52,690	72.28
2025-10-22	BUY	90	88.060	88.210	88.195	USD 7,938	70.77
2025-10-15	BUY	90	88.150	88.490	88.456	USD 7,961	70.35
2025-09-24	BUY	120	84.160	84.820	84.754	USD 10,170	69.68
2025-09-16	BUY	60	83.900	84.580	84.512	USD 5,071	69.44
2025-09-11	BUY	58	86.170	87.100	87.007	USD 5,046	69.35
2025-09-10	BUY	60	86.250	86.940	86.871	USD 5,212	69.26
2025-09-09	BUY	30	85.600	87.350	87.175	USD 2,615	69.17
2025-09-08	BUY	60	86.560	86.940	86.902	USD 5,214	69.08
2025-08-15	BUY	300	86.920	87.060	87.046	USD 26,114	68.50
2025-07-14	SELL	-90	69.980	70.040	70.034	USD -6,303	68.20 Loss of -165 on sale
2025-06-25	SELL	-180	67.550	69.140	68.981	USD -12,417	68.17 Loss of -145 on sale
2025-06-20	SELL	-120	68.460	69.190	69.117	USD -8,294	68.17 Loss of -113 on sale
2025-06-02	SELL	-360	65.310	65.970	65.904	USD -23,725	68.15 Profit of 807 on sale
2025-05-30	BUY	4,576	65.060	65.770	65.699	USD 300,639	68.17
2025-05-27	SELL	-275	65.350	65.800	65.755	USD -18,083	68.23 Profit of 680 on sale
2025-05-19	SELL	-200	63.810	64.300	64.251	USD -12,850	68.40 Profit of 830 on sale
2025-05-15	SELL	-200	62.760	62.990	62.967	USD -12,593	68.48 Profit of 1,103 on sale
2025-05-14	SELL	-100	61.160	62.500	62.366	USD -6,237	68.54 Profit of 618 on sale
2025-04-24	SELL	-50	58.970	59.050	59.042	USD -2,952	69.54 Profit of 525 on sale
2025-04-22	SELL	-75	57.380	58.040	57.974	USD -4,348	69.75 Profit of 883 on sale
2025-04-10	BUY	101	55.170	58.330	58.014	USD 5,859	70.70
2025-04-09	BUY	90	58.860	59.370	59.319	USD 5,339	70.81
2025-04-07	SELL	-408	60.290	61.060	60.983	USD -24,881	71.06 Profit of 4,110 on sale
2025-04-01	SELL	-206	60.910	62.000	61.891	USD -12,750	71.36 Profit of 1,951 on sale
2025-03-28	BUY	102	60.600	60.970	60.933	USD 6,215	71.59
2025-03-21	BUY	100	61.920	62.330	62.289	USD 6,229	72.13
2025-03-19	BUY	101	60.340	61.150	61.069	USD 6,168	72.40
2025-03-11	BUY	200	68.070	71.650	71.292	USD 14,258	72.90
2025-03-07	BUY	196	70.790	72.810	72.608	USD 14,231	72.95
2025-02-28	BUY	98	73.500	73.630	73.617	USD 7,214	73.06
2025-02-20	BUY	99	71.380	71.520	71.506	USD 7,079	73.05
2025-02-03	SELL	-480	73.740	75.000	74.874	USD -35,940	73.42 Loss of -697 on sale
2025-01-31	SELL	-97	74.160	75.180	75.078	USD -7,283	73.41 Loss of -162 on sale
2025-01-23	SELL	-97	72.530	72.880	72.845	USD -7,066	73.45 Profit of 59 on sale
2024-12-09	SELL	-100	72.110	75.980	75.593	USD -7,559	73.50 Loss of -210 on sale
2024-12-04	SELL	-99	74.620	75.320	75.250	USD -7,450	73.39 Loss of -184 on sale
2024-11-29	SELL	-198	74.590	76.080	75.931	USD -15,034	73.39 Loss of -502 on sale
2024-11-25	SELL	-6,950	73.520	73.870	73.835	USD -513,153	73.25 Loss of -4,093 on sale
2024-11-22	SELL	-124	71.720	72.000	71.972	USD -8,925	73.29 Profit of 163 on sale
2024-11-21	SELL	-124	70.390	71.400	71.299	USD -8,841	73.37 Profit of 257 on sale
2024-11-05	SELL	-123	77.280	77.370	77.361	USD -9,515	69.60 Loss of -955 on sale
2024-11-05	SELL	-123	77.280	77.370	77.361	USD -9,515	69.60 Loss of -955 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	321,923	395	451,110	71.4%
2025-09-18	244,947	1,423	469,747	52.1%
2025-09-17	277,858	779	546,953	50.8%
2025-09-16	359,781	946	576,379	62.4%
2025-09-15	347,453	4	582,228	59.7%
2025-09-12	353,040	0	631,534	55.9%
2025-09-11	448,733	3,894	739,701	60.7%
2025-09-10	490,727	248	671,932	73.0%
2025-09-09	515,395	1,822	682,791	75.5%
2025-09-08	308,184	119	479,828	64.2%
2025-09-05	256,719	2,505	512,049	50.1%
2025-09-04	422,624	1,507	834,717	50.6%
2025-09-03	381,679	7,777	624,922	61.1%
2025-09-02	547,120	15,396	816,267	67.0%
2025-08-29	148,294	262	304,427	48.7%
2025-08-28	164,008	0	347,480	47.2%
2025-08-27	248,926	453	513,401	48.5%
2025-08-26	365,130	6	709,320	51.5%
2025-08-25	478,130	1,306	642,319	74.4%
2025-08-22	344,352	2,023	596,301	57.7%
2025-08-21	198,729	4,881	335,301	59.3%
2025-08-20	351,699	3,977	555,345	63.3%
2025-08-19	343,110	3,146	574,328	59.7%
2025-08-18	366,124	4,996	653,103	56.1%
2025-08-15	480,885	8,035	625,797	76.8%
2025-08-14	593,554	36,654	806,068	73.6%
2025-08-13	845,181	98,160	1,257,503	67.2%
2025-08-12	462,896	42,208	678,689	68.2%
2025-08-11	385,211	696	595,892	64.6%
2025-08-08	248,925	738	426,187	58.4%
2025-08-07	268,864	929	420,486	63.9%
2025-08-06	554,642	891	731,484	75.8%
2025-08-05	361,687	2,092	623,879	58.0%
2025-08-04	338,005	1,464	519,150	65.1%
2025-08-01	414,814	828	572,879	72.4%
2025-07-31	570,845	6,148	777,417	73.4%
2025-07-30	471,303	14,166	881,194	53.5%
2025-07-29	966,640	10,581	1,593,701	60.7%
2025-07-28	382,236	62	625,510	61.1%
2025-07-25	216,967	49	422,990	51.3%
2025-07-24	348,276	23	528,517	65.9%
2025-07-23	297,903	583	487,297	61.1%
2025-07-22	267,987	172	446,489	60.0%
2025-07-21	223,626	380	406,729	55.0%
2025-07-18	241,218	108	471,589	51.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Edge MSCI World Value Factor UCITS USD Dist
Issuer	Blackrock
ETF Ticker	IWVG(GBP) LSE
ETF Ticker	IWVU(USD) LSE
ETF Ticker	IWVU.LS(USD) CXE
ETF Ticker	IWVUx(GBP) CXE
ETF Ticker	IWVG.L(GBP) LSE
ETF Ticker	IWVU.L(GBP) LSE